title: Inhibition of plasma kallikrein with aprotinin in porcine endotoxin shock.
abstract: Activation of the contact phase of coagulation has been implicated in the pathogenesis of septic shock. We wanted to determine if inhibition of plasma kallikrein can prevent arterial hypotension and liberation of kinins from kininogen, induced by an infusion of bacterial lipopolysaccharide (LPS) in anesthetized, ventilated 20-kg pigs. The LPS was given IV in a dose of 5 micrograms/kg/h for 8 hours. The plasma kallikrein inhibitor aprotinin, 537 mumol, was given IV during 8 hours, resulting in plasma levels above 10 mumol/L. Ten animals (SA) received LPS and aprotinin and ten randomized controls (SC) received LPS and saline. Kinin-containing kininogen was determined on the basis of the amount of kinin releasable in plasma samples by incubation with trypsin. Kininogen decreased to 58% +/- 4% of the baseline value without any difference between groups. This may indicate participation of other processes than degradation by plasma kallikrein in the decrease of kininogen. Arterial blood pressure was higher at 7 hours in the SA animals than in the SC group (101% +/- 11% vs. 68% +/- 8%; mean +/- SEM; p = 0.026). Fibrin monomer and C3adesArg plasma levels were attenuated by aprotinin treatment. These findings underscore the important role of the contact system in LPS shock.
authors.affiliation: Department of Surgery, University of Munich, Klinikum Innenstadt, Federal Republic of Germany.
authors.forename: M
authors.initials: M
authors.lastname: Siebeck
authors.forename: E
authors.initials: E
authors.lastname: Fink
authors.forename: J
authors.initials: J
authors.lastname: Weipert
authors.forename: M
authors.initials: M
authors.lastname: Jochum
authors.forename: H
authors.initials: H
authors.lastname: Fritz
authors.forename: M
authors.initials: M
authors.lastname: Spannagl
authors.forename: P
authors.initials: P
authors.lastname: Kroworsch
authors.forename: K
authors.initials: K
authors.lastname: Shimamoto
authors.forename: L
authors.initials: L
authors.lastname: Schweiberer
mesh_terms: D000818:Animals; D007611:Aprotinin / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects; D001794:Blood Pressure; D003167:Complement Activation / Q000187:drug effects; D015926:Complement C3a / Q000031:analogs & derivatives; D007457:Iodine Radioisotopes; D007610:Kallikreins / Q000032:analysis / Q000037:antagonists & inhibitors*; D007704:Kininogens / Q000032:analysis; D008070:Lipopolysaccharides; D008170:Lung Compliance; D011863:Radioimmunoassay; D012772:Shock, Septic / Q000503:physiopathology*; D013552:Swine; D013556:Swine, Miniature
chemical_list: D007457:Iodine Radioisotopes; D007704:Kininogens; D008070:Lipopolysaccharides; C044541:complement C3a, des-Arg-(77)-; D015926:Complement C3a; D007611:Aprotinin; D007610:Kallikreins